ABBVIE, INC. for ABBVIE INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 21, 2013 | $1,180,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 21, 2014 | $1,220,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Variety of international trade issues (CAFTA, TPA, TPP, KFTA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| ANDREW KAPLAN | — |
Taxation/Internal Revenue Code TAX
Proposals to reform domestic and international tax structures
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
| HEATHER STRAWN New | — |
| ADELE R WITENSTEIN | — |
Medicare/Medicaid MMM
Policies to enhance patient access to medicines in Medicare; Medicare payment proposals, S. 117/H.R. 1102 Medicare Prescription Drug Price Negotiation Act of 2013; S. 740/H.R. 1558 Medicare Drug Savings Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| ADELE R WITENSTEIN | — |
Budget/Appropriations BUD
H.R. 2725, Food & Drug Administration Safety Over Sequestration Act of 2013; S. 1413, FDA User Fee Protection Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| HEATHER STRAWN New | — |
Copyright/Patent/Trademark CPT
S. 214 Preserve Access to Affordable Generics Act of 2013; Numerous bills/drafts on Patent Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
Health Issues HCR
Public law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Reconciliation Act of 2010; BPCIA; Proposals to improve viral hepatitis screening and testing; S. 621 & H.R. 1285, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug; Implementation of the Prescription Drug User Fee Act (PDUFA); H.R. 3204, Drug Quality & Security Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL D BOYD | — |
| CATHERINE DRATZ FERGUSON | — |
| JOHN P. FORD | — |
| ANDREW KAPLAN | — |
| CHRISTOPHER LEIBUNDGUTH | — |
| ADELE R WITENSTEIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.